Expand IHE Menu
IHE MENU

IHE ETF Profile


Family: Blackrock (iShares)
Name: iShares US Pharmaceuticals ETF
Inception Date: 1-May-2006
Termination Date:
Investment Objective: The iShares Dow Jones U.S. Pharmaceuticals Index Fund seeks investment results that correspond generally to the price and yield performance before fees and expenses of the Dow Jones U.S. Select Pharmaceuticals Index.
Prospectus
Top 10 Holdings
JOHNSON & JOHNSON JNJ 23.6401%
ELI LILLY LLY 23.5271%
PFIZER INC PFE 5.0773%
BRISTOL MYERS SQUIBB BMY 4.8266%
MERCK & CO INC MRK 4.7858%
VIATRIS INC VTRS 4.6894%
ZOETIS INC CLASS A ZTS 4.4184%
ROYALTY PHARMA PLC CLASS A RPRX 3.7230%
INTRA CELLULAR THERAPIES INC ITCI 3.1380%
JAZZ PHARMACEUTICALS PLC JAZZ 2.8267%
Top 10 Holdings Weight: 80.7%
Number of Holdings: 47
Shares Outstanding: 9,300,000
Total Net Assets: 610,266,000
NAV: 65.66
Net Expense Ratio: 0.39%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Pharmaceuticals
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Broad Market / Multi-Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic